A recent large-scale survey of 2,981 Dutch e-cigarette users has found that without e-cigarettes, most people would smoke traditional cigarettes. The study was conducted by Dutch consumer organization Acvoda and trade association Esigbond, which represents approximately 400,000 e-cigarette users with an average age of 45. The research found that three-quarters of Dutch e-cigarette users would still smoke traditional cigarettes if e-cigarettes were not available.
A report reveals that nine out of ten e-cigarette users claim their health has improved after switching from smoking to electronic alternatives.
The collected data shows that smokers attempted to quit an average of 5.1 times before switching to e-cigarettes. 63% of e-cigarette users reported using them as a less harmful substitute for traditional cigarettes, while 54% did so as part of a quit smoking attempt. Additionally, 46% noted that they could not have quit smoking without the help of e-cigarettes. The availability of different flavor options played a significant role in encouraging this transition, according to 81% of respondents.
Despite these statistics, local authorities are still considering banning flavored e-cigarettes. The European Tobacco Harm Reduction Advocates (ETHRA) emphasizes that the proposed change "essentially amounts to an invisible ban on all e-liquids.
Meanwhile, Sweden has received praise not only for achieving a smoke-free status, but also for recently rejecting a ban on snus. As part of a survey investigating smoking behavior across the European Union, a chart released by the EU in May 2017 identified Bulgaria, Greece, and France as the countries with the highest percentages of smokers, with rates of 36%, 35%, and 33%, respectively. The Netherlands, Denmark, and the United Kingdom were ranked at the bottom, all with a rate of 16%. Impressively, Sweden ranked last with only 5% of its population smoking.
Sweden has achieved its current position by implementing a harm reduction strategy and supporting the ban on smoking, as well as endorsing the use of snus as a smoking cessation aid. Snus refers to a moist powder tobacco product that can be placed under the upper lip for extended periods of time.
The product is most popular in Sweden, Denmark and Norway, but it is only legal in Sweden and is considered an effective harm reduction tobacco product. In fact, snuff not only makes Sweden the country with the lowest smoking rate in Europe, but more importantly, it also makes Sweden the country with the lowest lung cancer incidence on the entire European continent.
Statement:
This article is compiled based on third-party information and is intended for industry professionals for learning and exchange purposes.
This article does not represent the opinion of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research.
Due to limitations in translation abilities, the compiled article may not fully express the original text. Therefore, the original text should be considered as the final authority.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign issues or positions.
The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
